Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same
US7964711B2 · kind B2 · utility
4Cited by
9References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2009 |
| Grant date | Jun 21, 2011 |
| Priority date | — |
| Expiry date | Oct 26, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.